TCM Ltd
Incorporated in 1943, TCM Ltd manufactures chemicals having and trades solar equipments and healthcare devices[1]
- Market Cap ₹ 30.1 Cr.
- Current Price ₹ 40.2
- High / Low ₹ 79.5 / 35.0
- Stock P/E 21.5
- Book Value ₹ 40.8
- Dividend Yield 0.00 %
- ROCE 5.73 %
- ROE 4.72 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 1.02 times its book value
- Debtor days have improved from 141 to 95.0 days.
Cons
- Company has a low return on equity of -5.20% over last 3 years.
- Earnings include an other income of Rs.4.47 Cr.
- Working capital days have increased from 9.62 days to 348 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
0.40 | 0.92 | 4.23 | 3.55 | 7.35 | 32.23 | 26.01 | |
1.26 | 1.75 | 5.11 | 7.56 | 11.01 | 34.45 | 28.17 | |
Operating Profit | -0.86 | -0.83 | -0.88 | -4.01 | -3.66 | -2.22 | -2.16 |
OPM % | -215.00% | -90.22% | -20.80% | -112.96% | -49.80% | -6.89% | -8.30% |
0.04 | 1.15 | 1.23 | -1.69 | 0.02 | 0.43 | 4.47 | |
Interest | 0.12 | 0.01 | 0.01 | 0.01 | 0.28 | 0.16 | 0.59 |
Depreciation | 0.00 | 0.01 | 0.03 | 0.17 | 0.37 | 0.30 | 0.35 |
Profit before tax | -0.94 | 0.30 | 0.31 | -5.88 | -4.29 | -2.25 | 1.37 |
Tax % | 0.00% | 0.00% | 61.29% | 0.00% | -0.70% | 1.78% | -2.19% |
-0.95 | 0.30 | 0.12 | -5.88 | -4.27 | -2.29 | 1.40 | |
EPS in Rs | -1.27 | 0.40 | 0.16 | -6.85 | -5.35 | -2.61 | 2.15 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 95% |
3 Years: | 94% |
TTM: | -19% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 36% |
3 Years: | 35% |
TTM: | 172% |
Stock Price CAGR | |
---|---|
10 Years: | -3% |
5 Years: | 8% |
3 Years: | 11% |
1 Year: | -17% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | -5% |
3 Years: | -5% |
Last Year: | 5% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
Equity Capital | 3.40 | 3.40 | 3.40 | 3.40 | 7.48 | 7.48 | 7.48 |
Reserves | 29.02 | 29.07 | 29.19 | 21.93 | 23.26 | 21.31 | 23.04 |
5.38 | 5.64 | 5.83 | 6.53 | 1.44 | 0.27 | 11.22 | |
31.35 | 27.33 | 29.32 | 29.58 | 36.63 | 54.74 | 34.66 | |
Total Liabilities | 69.15 | 65.44 | 67.74 | 61.44 | 68.81 | 83.80 | 76.40 |
58.01 | 58.01 | 58.82 | 55.28 | 35.70 | 17.28 | 14.19 | |
CWIP | 0.00 | 0.00 | 0.06 | 0.02 | 0.10 | 0.10 | 0.00 |
Investments | 0.44 | 0.19 | 0.18 | 0.00 | 0.00 | 0.00 | 0.30 |
10.70 | 7.24 | 8.68 | 6.14 | 33.01 | 66.42 | 61.91 | |
Total Assets | 69.15 | 65.44 | 67.74 | 61.44 | 68.81 | 83.80 | 76.40 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
-1.63 | -0.57 | 0.39 | -4.21 | -10.87 | 1.95 | -10.08 | |
0.01 | 0.00 | -0.51 | 4.22 | 5.84 | -0.64 | -0.18 | |
5.32 | -3.14 | 0.18 | 0.19 | 4.87 | -1.30 | 10.37 | |
Net Cash Flow | 3.69 | -3.70 | 0.06 | 0.20 | -0.15 | 0.00 | 0.11 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
Debtor Days | 1,377.88 | 706.20 | 217.45 | 195.35 | 232.90 | 96.37 | 95.00 |
Inventory Days | 1,477.38 | 847.92 | 467.90 | 192.33 | 269.66 | 852.04 | 570.68 |
Days Payable | 2,581.07 | 1,914.85 | 743.59 | 77.21 | 91.78 | 78.57 | 50.16 |
Cash Conversion Cycle | 274.18 | -360.73 | -58.24 | 310.47 | 410.78 | 869.84 | 615.52 |
Working Capital Days | -6,077.25 | -1,023.59 | -314.95 | -691.96 | -419.13 | 100.11 | 347.88 |
ROCE % | 0.82% | -0.16% | -10.58% | -12.90% | -7.04% | 5.73% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
30 May - Copies of Newspaper clippings regarding Audited Consolidated and Standalone Financial Results for the Quarter ended 31st March 2025 published on Friday, 30th May 2025 in …
-
Revised Outcome Of The Board Meeting After Inclusion Of The ''Declaration To The Effect That Auditors Report On Audited Financials Is With Unmodified Opinion''.
30 May - TCM Limited reports audited FY25 standalone and consolidated results with profit before tax Rs.311.52L and Rs.136.53L respectively.
-
Board Comments On SOP Fines Levied
29 May - TCM Limited fined Rs.2,360 by BSE for delayed shareholding pattern submission; fine paid and compliance assured.
-
Board Meeting Outcome for Outcome Of The Board Meeting And Consolidated & Standalone Audited Financial Statements For The Year Ended 31St March 2025
29 May - TCM Limited reports audited FY25 standalone and consolidated results with profit before tax Rs.311.52 lakhs standalone, Rs.136.53 lakhs consolidated.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
27 May - Annual Secretarial Compliance Report for FY ended 31 Mar 2025; minor one-day filing delay with late fee paid.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
-
Financial Year 2008
from bse
Business Overview:[1]
Company trading of medical products,
GPS-enabled Automatic Headlight Beam Assist System for vehicles under the brand name of ENSO, and the business of setting up and commissioning Solar Power plants